Cerulean Pharma Inc Stock Nasdaq
Equities
US15708Q1058
Biotechnology & Medical Research
Sales 2024 * | 15.62M 21.36M | Sales 2025 * | 30.24M 41.36M | Capitalization | 31.7M 43.36M |
---|---|---|---|---|---|
Net income 2024 * | -17M -23.25M | Net income 2025 * | -9M -12.31M | EV / Sales 2024 * | 2.03 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.05 x |
P/E ratio 2024 * |
-1.97
x | P/E ratio 2025 * |
-3.78
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.35% |
Latest transcript on Cerulean Pharma Inc
Managers | Title | Age | Since |
---|---|---|---|
Sabrina Johnson
FOU | Founder | 57 | 14-12-31 |
Annie Thurman
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Jessica Hatheway
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robin Steele
BRD | Director/Board Member | 68 | 14-12-31 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 19-11-19 |
Chairman | 76 | 13-12-31 |
1st Jan change | Capi. | |
---|---|---|
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+46.00% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |